196 related articles for article (PubMed ID: 24191663)
1. A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
Iorio M; Sasso O; Maffioli SI; Bertorelli R; Monciardini P; Sosio M; Bonezzi F; Summa M; Brunati C; Bordoni R; Corti G; Tarozzo G; Piomelli D; Reggiani A; Donadio S
ACS Chem Biol; 2014 Feb; 9(2):398-404. PubMed ID: 24191663
[TBL] [Abstract][Full Text] [Related]
2. Substrate tolerance of the biosynthetic enzymes of glycosylated lanthipeptide NAI-112.
Sheng W; Xu B; Chen S; Li Y; Liu B; Wang H
Org Biomol Chem; 2020 Aug; 18(31):6095-6099. PubMed ID: 32700722
[TBL] [Abstract][Full Text] [Related]
3. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
[TBL] [Abstract][Full Text] [Related]
4. Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362.
Boakes S; Appleyard AN; Cortés J; Dawson MJ
J Antibiot (Tokyo); 2010 Jul; 63(7):351-8. PubMed ID: 20520597
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in lanthipeptide biosynthesis - A review].
Mo T; Xue L; Zhang Q
Wei Sheng Wu Xue Bao; 2016 Mar; 56(3):373-82. PubMed ID: 27382781
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Labionin-Containing Peptides and Sactibiotics: Unusual Types of Antimicrobial Peptides with Potential Use in Clinical Settings (a Review).
Varella Coelho ML; de Souza Duarte AF; do Carmo de Freire Bastos M
Curr Top Med Chem; 2017; 17(10):1177-1198. PubMed ID: 27697045
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.
Simone M; Monciardini P; Gaspari E; Donadio S; Maffioli SI
J Antibiot (Tokyo); 2013 Feb; 66(2):73-8. PubMed ID: 23168402
[TBL] [Abstract][Full Text] [Related]
8. Improving the attrition rate of Lanthipeptide discovery for commercial applications.
Geng M; Smith L
Expert Opin Drug Discov; 2018 Feb; 13(2):155-167. PubMed ID: 29195488
[TBL] [Abstract][Full Text] [Related]
9. The Supersized Class III Lanthipeptide Stackepeptin Displays Motif Multiplication in the Core Peptide.
Jungmann NA; van Herwerden EF; Hügelland M; Süssmuth RD
ACS Chem Biol; 2016 Jan; 11(1):69-76. PubMed ID: 26488920
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the congeners in the lantibiotic NAI-107 complex.
Maffioli SI; Iorio M; Sosio M; Monciardini P; Gaspari E; Donadio S
J Nat Prod; 2014 Jan; 77(1):79-84. PubMed ID: 24422756
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic aspects of lanthipeptide leaders.
Plat A; Kuipers A; Rink R; Moll GN
Curr Protein Pept Sci; 2013 Mar; 14(2):85-96. PubMed ID: 23441895
[TBL] [Abstract][Full Text] [Related]
12. Structure and genetics of circular bacteriocins.
van Belkum MJ; Martin-Visscher LA; Vederas JC
Trends Microbiol; 2011 Aug; 19(8):411-8. PubMed ID: 21664137
[TBL] [Abstract][Full Text] [Related]
13. Identification of Putative Novel Class-I Lanthipeptides in Firmicutes: A Combinatorial
Alkhalili RN; Canbäck B
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200662
[TBL] [Abstract][Full Text] [Related]
14. Heterologous expression and engineering studies of labyrinthopeptins, class III lantibiotics from Actinomadura namibiensis.
Krawczyk JM; Völler GH; Krawczyk B; Kretz J; Brönstrup M; Süssmuth RD
Chem Biol; 2013 Jan; 20(1):111-22. PubMed ID: 23352145
[TBL] [Abstract][Full Text] [Related]
15. Evolution of lanthipeptide synthetases.
Zhang Q; Yu Y; Vélasquez JE; van der Donk WA
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18361-6. PubMed ID: 23071302
[TBL] [Abstract][Full Text] [Related]
16. Improved lanthipeptide detection and prediction for antiSMASH.
Blin K; Kazempour D; Wohlleben W; Weber T
PLoS One; 2014; 9(2):e89420. PubMed ID: 24586765
[TBL] [Abstract][Full Text] [Related]
17. Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase.
Krawczyk B; Völler GH; Völler J; Ensle P; Süssmuth RD
Chembiochem; 2012 Sep; 13(14):2065-71. PubMed ID: 22907786
[TBL] [Abstract][Full Text] [Related]
18. Functional Genome Mining Reveals a Class V Lanthipeptide Containing a d-Amino Acid Introduced by an F
Xu M; Zhang F; Cheng Z; Bashiri G; Wang J; Hong J; Wang Y; Xu L; Chen X; Huang SX; Lin S; Deng Z; Tao M
Angew Chem Int Ed Engl; 2020 Oct; 59(41):18029-18035. PubMed ID: 32648341
[TBL] [Abstract][Full Text] [Related]
19. Class I and Class II Lanthipeptides Produced by Bacillus spp.
Barbosa J; Caetano T; Mendo S
J Nat Prod; 2015 Nov; 78(11):2850-66. PubMed ID: 26448102
[TBL] [Abstract][Full Text] [Related]
20. Structural Characterization and Bioactivity Analysis of the Two-Component Lantibiotic Flv System from a Ruminant Bacterium.
Zhao X; van der Donk WA
Cell Chem Biol; 2016 Feb; 23(2):246-256. PubMed ID: 27028884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
